BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 6794980)

  • 21. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
    Landgren BM; Diczfalusy E
    Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
    Snowden EU; Khan-Dawood FS; Dawood MY
    Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ethinyl estradiol 20 mcg and levonorgestrel 250 mcg on the pituitary-ovarian function during normal tablet-taking and when tablets are missed.
    Nuttall ID; Elstein M; McCafferty E; Seth J; Cameron ED
    Contraception; 1982 Aug; 26(2):121-35. PubMed ID: 6814817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
    Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR
    Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilization.
    Mashiach S; Dor J; Goldenberg M; Shalev J; Levran D; Rudak E; Nebel L; Goldman B; Blankstein J; Ben-Rafael Z
    Gynecol Endocrinol; 1989 Jun; 3(2):107-15. PubMed ID: 2816477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O; Gordon K; Williams RF; Hodgen GD
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
    Ling WY; Wrixon W; Acorn T; Wilson E; Collins J
    Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on low dose oral contraceptives: plasma hormone changes in relation to deliberate pill ('Microgynon 30') omission.
    Morris SE; Groom GV; Cameron ED; Buckingham MS; Everitt JM; Elstein M
    Contraception; 1979 Jul; 20(1):61-9. PubMed ID: 477318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary-ovarian activity when switching from various monophasic pills to a triphasic pill.
    Eyong E; Priddy AR; Killick SR; Elstein M
    Adv Contracept; 1989 Mar; 5(1):1-11. PubMed ID: 2528892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
    Aden U; Jung-Hoffmann C; Kuhl H
    Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental studies on the positive feedback effect of progesterone, 17 alpha-hydroxyprogesterone and 20 alpha-dihydroprogesterone on the pituitary release of LH and FSH in the human female. The estrogen priming of the progesterone feedback on pituitary gonadotropins in the eugonadal woman.
    Leyendecker G; Wildt L; Gips H; Nocke W; Plotz EJ
    Arch Gynakol; 1976; 221(1):29-45. PubMed ID: 989265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The acute feedback action of exogenously administered oestrogens on the serum-gonadotropin-levels in pre- and postmenopausal women (author's transl)].
    Czygan PJ; Reich W
    Arch Gynakol; 1973 May; 215(1):17-38. PubMed ID: 4582609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.